LVAD as a Bridge to Transplantation—Current Status and Future Perspectives
Reviews in Cardiovascular Medicine · 17.05.2024 · 25 (5)
DOI: 10.31083/j.rcm2505176 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 17.05.2024. Verfasst von Maximilian J Roesel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), 13353 Berlin, Germany. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Junior Clinician Scientist Program of the Berlin Institute of Health and received funding from the German Centre for Cardiovascular Research.
Abstract (Originalsprache)
Heart failure (HF) is a common disease associated with high morbidity and mortality rates despite advanced pharmacological therapies. Heart transplantation remains the gold standard therapy for end-stage heart failure; however, its application is curtailed by the persistent shortage of donor organs. Over the past two decades, mechanical circulatory support, notably Left Ventricular Assist Devices (LVADs), have been established as an option for patients waiting for a donor organ. This comprehensive review focuses on elucidating the benefits and barriers associated with this application. We provide an overview of landmark clinical trials that have evaluated the use of LVADs as a bridge to transplantation therapy, with a particular focus on post-transplant outcomes. We discuss the benefits of stabilizing patients with these systems, weighing associated complications and limitations. Further technical advancements and research on optimal implantation timing are critical to ultimately improve outcomes and securing quality of life. In a world where the availability of donor organs remains constrained, LVADs are an increasingly important piece of patient care, bridging the critical gap to transplantation in advanced heart failure management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), 13353 Berlin, Germany.
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Berlin, 10785 Berlin, Germany.
- Department of Cardio-, Thoracic-, Transplantation-, and Vascular Surgery, Medizinische Hochschule Hannover, 30625 Hannover, Germany.
- Berlin Institutes of Health at Charité - Universitätsmedizin Berlin, 10178 Berlin, Germany.
Förderung
- Junior Clinician Scientist Program of the Berlin Institute of Health and received funding from the German Centre for Cardiovascular Research
Zitieren
APA
Roesel, M. J., Nersesian, G., Neuber, S., Thau, H., Wolff von Gudenberg, R., Lanmueller, P., Hennig, F., Falk, V., Potapov, E., Knosalla, C., & Iske, J. (2024). LVAD as a Bridge to Transplantation—Current Status and Future Perspectives. Reviews in Cardiovascular Medicine, 25(5). https://doi.org/10.31083/j.rcm2505176
Vancouver
Roesel MJ, Nersesian G, Neuber S, Thau H, Wolff von Gudenberg R, Lanmueller P, et al. LVAD as a Bridge to Transplantation—Current Status and Future Perspectives. Reviews in Cardiovascular Medicine. 2024;25(5). doi:10.31083/j.rcm2505176
BibTeX
@article{Roesel2024,
author = {Roesel, Maximilian J and Nersesian, Gaik and Neuber, Sebastian and Thau, Henriette and Wolff von Gudenberg, Rosalie and Lanmueller, Pia and Hennig, Felix and Falk, Volkmar and Potapov, Evgenij and Knosalla, Christoph and Iske, Jasper},
title = {LVAD as a Bridge to Transplantation—Current Status and Future Perspectives},
journal = {Reviews in Cardiovascular Medicine},
year = {2024},
volume = {25},
number = {5},
doi = {10.31083/j.rcm2505176}
}
EUVIMED